The first government - funded
human genomics research study performed on African soil — aimed at unlocking the unique genetic character of southern African populations — has revealed a high level of genetic diversity.
In a 2016 National Institutes of Health summer internship at the National
Human Genomic Research Institute, Sappington conducted a third research project in which she demonstrated a fast, alignment - free computational method for identifying orthologs — similar genes from species that are related by descent from a common ancestor.
In this session, we will discuss methods for integrated analysis of DNA and RNA and their application in
human genomic research in the areas of cancer genomics, human disease research, and regulation of gene expression.
Not exact matches
His institute is a leading
research organization dedicated to
genomic research, and he's the co-founder, chairman and CEO of
Human Longevity.
His institute is a leading organization dedicated to
genomic research, and he's the co-founder, executive chairman and CEO of
Human Longevity.
Last June, he switched to the Department of
Human DNA Variability at the Centre for
Genomic and Oncological
Research in Granada.
Even though Rienhoff is the founder of two biotechnology companies and holds a medical degree from Johns Hopkins University, he has conducted his hunt not as an expert in
human genomics but as a do - it - yourself biologist, teaching himself the tricks of the trade as he moves along and doing his
research at home.
«They are developing the clinical
genomics necessary to foster and support the Precision Medicine Initiative of the National Institutes of Health, and generating the
genomics data that further drives
human genome
research.»
Using
genomic analysis to study cancer in dogs can help develop new therapies for
humans with cancer, according to a proof - of - concept study led by the National Cancer Institute (NCI) and the Translational Genomics
Research Institute (TGen).
The move comes in response to the announcement earlier this week of a new U.S. company, launched by sequencing - machine manufacturer Perkin - Elmer and J. Craig Venter of The Institute for
Genomic Research, that plans a brute - force approach to sequencing the
human genome within 3 years (ScienceNOW, 12 May).
«Right now, the
research group is analyzing the nuclear genome the results of which could provide us with information about its relationship with the Neanderthals and about the existence of
genomic variations associated with the immune system that accounts for the evolutionary success of Homo sapiens over other
human species with whom it co-existed.
The institute, called the Institute for
Genomic Research, is funded by a ten - year, $ 70 million grant from
Human Genome Sciences, a private company set up by venture capitalists.
The U.S. National
Human Genome
Research Institute and the National Academy of Medicine recently brought together 25 of these groups to compare projects, to examine the current state of implementation and desired near - term capabilities, and to identify opportunities for collaboration that promote the responsible practice of
genomic medicine.
Indeed, according to a report last year by the
research and management organization Battelle, «In 2010 alone, the
human genome sequencing projects and associated
genomics research and industry activity directly and indirectly generated $ 67 billion in U.S. economic output and supported 310,000 jobs that produced $ 20 billion in personal income.»
That is why a second group of scientists — including J. Craig Venter, the entrepreneur and biologist whose Institute for
Genomic Research in Rockville, Md., played a key role in mapping the
human genome — argues for a bolder approach.
During the last several years,
research efforts with
human cell lines revealed that the
genomic loci encoding tRNAs give rise to shorter tRNA fragments («tRFs»).
But John Quackenbush of The Institute for
Genomic Research (TIGR) in Rockville, Maryland, put his dollar on 118,259 genes, an estimate based on the genes in TIGR's
human gene index, while a 153,478 - genes entry came in from Sam LaBrie of Incyte Genomics, a California - based company that in September 1999 announced that the
human genome had at least 140,000 genes.
I see firsthand how their efforts help people understand and appreciate
genomics research and its impact on
human health.»
The Obama Administration is exploring fundamental reforms to
human subjects protections — actions that are being driven in part by the fact that technological advances, especially in
genomics and computing, have made the notion of «de-identifying» a
research participant's biological sample virtually impossible.
The hostilities involve institutions (M.I.T. and Harvard versus University of California), gender (Doudna, Charpentier, Zhang), geography (east versus west coast) and what you might call über - institutions (the Broad Institute, which has become an empire of
genomic research under Lander's direction, especially after his leading role in the
Human Genome Project, versus the Howard Hughes Medical Institute, whose president, Robert Tjian, is based at Berkeley and has co-authored at least one CRISPR paper with Doudna, also an HHMI investigator).
Coleman added that further
research is needed to determine whether cell fusion events between normal
human cell types result in
genomic catastrophe and neoplastic transformation.
In 2003, in «A vision for the future of
genomics research,» Francis Collins — who was then the director of the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health — and his co-authors encouraged collaboration between basic scientists and clinical scientists, and between life scientists and social scientists, to address the ethical, legal, and social implications of genomic and genetic research and the resulting new techn
research,» Francis Collins — who was then the director of the National
Human Genome
Research Institute (NHGRI), part of the National Institutes of Health — and his co-authors encouraged collaboration between basic scientists and clinical scientists, and between life scientists and social scientists, to address the ethical, legal, and social implications of genomic and genetic research and the resulting new techn
Research Institute (NHGRI), part of the National Institutes of Health — and his co-authors encouraged collaboration between basic scientists and clinical scientists, and between life scientists and social scientists, to address the ethical, legal, and social implications of
genomic and genetic
research and the resulting new techn
research and the resulting new technologies.
Led by scientists at The Institute for
Genomic Research (TIGR) in Rockville, Maryland, and the Wellcome Trust Sanger Institute in the United Kingdom, the study indicates that the amoeba has snagged an astonishing 92 genes from bacteria in recent times, presumably by gobbling them up during its life in the
human gut.
The study analyzed data from The Cancer Genome Atlas (TCGA), a
research program supported by the National Cancer Institute and National Human Genome Research Institute within the National Institutes of Health that is looking at genomic changes in more than 20 different types of
research program supported by the National Cancer Institute and National
Human Genome
Research Institute within the National Institutes of Health that is looking at genomic changes in more than 20 different types of
Research Institute within the National Institutes of Health that is looking at
genomic changes in more than 20 different types of cancer.
A collaboration of premier academic, medical and industry leaders across the globe, the New York Genome Center has as its goal to translate
genomic research into the development of new treatments, therapies and therapeutics against
human disease.
«The availability of the
human genome sequence, as well as other
genomic resources produced by our sequencing centers, has transformed biomedical
research everywhere,» said NHGRI's Associate Director of Extramural Research Jane Peterson, Ph.D., who is also a program director for NHGRI's Large - Scale Sequencing Research
research everywhere,» said NHGRI's Associate Director of Extramural
Research Jane Peterson, Ph.D., who is also a program director for NHGRI's Large - Scale Sequencing Research
Research Jane Peterson, Ph.D., who is also a program director for NHGRI's Large - Scale Sequencing
Research Research Network.
The code does not place unrealistic demands on scientists, says Himla Soodyall, director of the
Human Genomic Diversity and Disease
Research Unit at South Africa's University of the Witwatersrand in Johannesburg.
Robert Wildin, M.D., a clinical geneticist with nearly three decades of experience in private and hospital - based medical practice, joined the National
Human Genome
Research Institute (NHGRI) on Nov. 10, 2014 as chief of the
Genomic Healthcare Branch (GHB).
The branch also serves as an informational resource and liaison for parties interested in policy matters related to
human genetics and
genomics research.
The INFRAFRONTIER mission: ◊ to shape the European
Research Area in the field of mouse functional
genomics and thereby make an important contribution to the study of
human disease.
The debate about
genomic editing of
human embryos is unlikely to follow the recommendations for systematic forethought proposed by illustrious
research bodies and reports.
Research interests: primate comparative
genomics, adaptive evolution,
human brain evolution, infectious diseases in primate hosts, HIV / SIV and AIDS, evolutionary medicine, colobines
The advent of accessible and relatively inexpensive high - throughput sequencing technology has resulted in extensive sequencing of whole
human genomes or exomes in a
research setting and seems likely to lead to an explosion of
genomic sequencing in a clinical context.
He recently moved back to academia as an associate professor in the departments of Neuroscience and
Human Genetics &
Genomic Sciences at the Icahn School of Medicine at Mount Sinai in New York, where he continues his basic
research and translational efforts in AD using a state - of - the - art experimental and computational toolkit, in collaboration with Drs. Alison Goate and Anne Schaefer within the Ronald M. Loeb Center for Alzheimer's Disease.
Founded by J. Craig Venter, Ph.D., the JCVI is home to approximately 300 scientists and staff with expertise in
human and evolutionary biology, genetics, bioinformatics / informatics, information technology, high - throughput DNA sequencing,
genomic and environmental policy
research, and public education in science.
Participating institutions: Helmholtz Association • CNRS • Institute of Molecular Biotechnology •
Research Center for Molecular Medicine of the Austrian Academy of Sciences • VIB - KU Leuven • Friedrich Miescher Institute for Biomedical
Research • University of Basel • University of Zurich • Central European Institute of Technology • Max Planck Institute of Immunobiology and Epigenetics • Max Planck Institute for Molecular Genetics • German Cancer
Research Center • Max Delbrück Center for Molecular Medicine • German Center for Neurodegenerative Diseases • Helmholtz Zentrum München • Max Planck Institute for Evolutionary Anthropology • Helmholtz Institute of RNA - based Infection
Research • Saarland University • Technical University Munich • University of Würzburg • Biotech
Research & Innovation Centre • Interdisciplinary Nanoscience Center • University of Copenhagen • Centre for
Genomic Regulation • Institut Curie • Université de Montpellier • Inserm • Université Toulouse III — Paul Sabatier • École nationale supérieure des mines de Paris • Institute for Molecular Medicine Finland • The Biomedical
Research Foundation, Academy of Athens • Weizmann Institute of Science • Hebrew University • Sapienza — University of Rome • Instituto Nazionale Genetica Molecolare • University of Napoli • University of Padua • University of Milan • European Institute of Oncology • Netherlands Cancer Institute • Radboud University • University Medical Center Utrecht • Hubrecht Institute • Instituto Gulbenkian de Ciência • Institute of Bioorganic Chemistry of the Polish Academy of Sciences • Romanian Center for Systems Immunology • Karolinska Institute • MRC
Human Genetics Unit • University of Edinburgh • Wellcome Sanger Institute • The Babraham Institute • European Molecular Biology Laboratory — European Bioinformatics Institute
Joshua leads the
Human Genetics Informatics team, who are responsible for handling the informatics needs of the
Human Genetics
research programme, including processing of large - scale genetics and
genomics data sets.
Dr. Torkamani's
research covers a broad range of areas centered on the use of
genomic technologies to identify the genetic etiology and underlying mechanisms of
human disease in order to define precision therapies for diseased individuals.
Working with collaborators in more than 20 countries, primarily through MalariaGEN, Dominic's
research focuses on investigating the biological and clinical consequences of
genomic variation in
human, Plasmodium and Anopheles populations.
Teri Manolio, Director, Division of
Genomic Medicine, National
Human Genome
Research Institute, USA
Liu's scientific
research focuses on the functional
genomics of
human cancers, particularly breast cancer, uncovering new oncogenes, and deciphering on a
genomic scale the dynamics of gene regulation that modulate cancer biology.
Moderator: Teri Manolio, Director, Division of
Genomic Medicine, National
Human Genome
Research Institute (USA)
She has made an important contribution to several international
research consortia in
human genomics, including the Genotype Tissue Expression (GTEx) Project, the 1000 Genomes Project and led the RNA - sequencing work of the Geuvadis Consortium.
BETHESDA, Md., Thurs., Oct. 14, 2004 - The National
Human Genome
Research Institute (NHGRI), part of the National Institutes of Health (NIH), today announced it has awarded more than $ 38 million in grants to spur the development of innovative technologies designed to dramatically reduce the cost of DNA sequencing, a move aimed at broadening the applications of genomic information in medical research and heal
Research Institute (NHGRI), part of the National Institutes of Health (NIH), today announced it has awarded more than $ 38 million in grants to spur the development of innovative technologies designed to dramatically reduce the cost of DNA sequencing, a move aimed at broadening the applications of
genomic information in medical
research and heal
research and health care.
The
Genomic Medicine Institute (GMI) and the Center for Clinical Genomics are excited to announce a broad
research collaboration with
Human Longevity Inc., (HLI), Dr. J. Craig Venter's company in San Diego, CA.
Interface of Genomics
Research and
Genomic Medicine Recent advances in DNA sequencing technologies mean that it is now possible to conduct genomic analyses, including analysis of the entire genome of an individual human, that just a few years ago would have been too costly an
Genomic Medicine Recent advances in DNA sequencing technologies mean that it is now possible to conduct
genomic analyses, including analysis of the entire genome of an individual human, that just a few years ago would have been too costly an
genomic analyses, including analysis of the entire genome of an individual
human, that just a few years ago would have been too costly and slow.
The JCVI teams are focused on a variety of
genomic research areas including continued work in synthetic biology; sampling and analysis of the world's oceans, fresh water and soils to better understand the microbes living in these environments; and new analysis on the
human genome in the hopes of discovering new insights into disease prevention and treatment.
Ageing
research and more generally the study of the functional basis of
human diseases profit enormously from the large - scale approaches and resources in mouse functional
genomics: systematic targeted mutation of the mouse genome, systemic phenotyping in mouse clinics, and the archiving and distribution of the mouse resources in public repositories.
Diversity in
Genomics Research Cohorts The lack of diversity within participant cohorts in genetics and genomics research limits our ability to study variation across the human genome and the genetic factors that influence health and disease, as well as our ability to ensure that every segment of the population is able to benefit from advances stemming from the r
Research Cohorts The lack of diversity within participant cohorts in genetics and
genomics research limits our ability to study variation across the human genome and the genetic factors that influence health and disease, as well as our ability to ensure that every segment of the population is able to benefit from advances stemming from the r
research limits our ability to study variation across the
human genome and the genetic factors that influence health and disease, as well as our ability to ensure that every segment of the population is able to benefit from advances stemming from the
researchresearch.
«Martin Pera brings an unparalleled depth of expertise in embryonic and pluripotent stem cell biology to our faculty, complementing and broadening our emerging
research emphasis on
human genomic medicine,» said Edison Liu, M.D., president and CEO of The Jackson Laboratory.